Matches in SemOpenAlex for { <https://semopenalex.org/work/W2622017248> ?p ?o ?g. }
Showing items 1 to 84 of
84
with 100 items per page.
- W2622017248 abstract "530 Background: Therapeutic efficacy of H involves activation of the immune system.Age-dependent progressive deterioration of the immune response is referred as immunosenescence. In HER2+ breast cancer, the effects of aging and the ability of H to activate endogenous anti-tumor immunity is unknown. A previous report from HERA trial showed no significant increase in risk of early recurrence with age (≤ or > 40). We evaluated the long-term outcome of HER2+ patients (pt) related to age and immune landscape. Methods: 1,392 pt from N9831 trial were evaluated. Stromal tumor infiltrating lymphocytes (sTIL) were evaluated in H&E slides. Lymphocyte predominant breast cancer (LPBC) was defined as sTIL ≥ 50%. Molecular TIL (mTIL) and immune subset signatures were evaluated using NanoString research CodeSets. Cox proportional hazard ratio (HR) was used for analysis. Results: There were 1,111 (79.8%) pt > 40 years old (yo) and 281 (20.2%) pt ≤ 40 yo. Younger age was significantly associated with hormone receptor positivity (p 0.00011) and luminal B subtype (p 0.011). With a median follow up of 10.6 years, there was no significant difference in long-term outcome among pt ≤ 40 vs. > 40 yo who received H (HR = 0.88 (0.62-1.24), p = 0.45). Similar findings were observed when age was dichotomized at 50 and 60 yo. While there was no association between sTIL and age, a small but significant increase in mTIL CD45 expression with age (p 0.003) was observed. Similar small increases in cytotoxic cell (p 0.007) and T cell (p 0.015) immune scores were also observed with increasing age. Among pt who received chemotherapy alone, pt > 40 yo with LPBC (n 55) had excellent outcome with 92.4% recurrence free survival (RFS) at 10 years. However, there was no significant difference in RFS among pt ≤ 40 yo with or without LPBC. Conclusions: Among pt treated with H, there was no significant difference in outcome related to age. In contrast to a decline expected from immunosenescence, we observed small but significant increases in mTIL signatures for total lymphocytes, cytotoxic, and T cell subsets. Among patients who received chemotherapy alone, our data suggested that pt > 40 yo with LPBC had excellent prognosis, compared to pt > 40 yo without LPBC." @default.
- W2622017248 created "2017-06-15" @default.
- W2622017248 creator A5014209331 @default.
- W2622017248 creator A5026692399 @default.
- W2622017248 creator A5027821205 @default.
- W2622017248 creator A5031005364 @default.
- W2622017248 creator A5033771723 @default.
- W2622017248 creator A5034422841 @default.
- W2622017248 creator A5052187738 @default.
- W2622017248 creator A5057155689 @default.
- W2622017248 creator A5065306642 @default.
- W2622017248 creator A5082913203 @default.
- W2622017248 date "2017-05-20" @default.
- W2622017248 modified "2023-09-24" @default.
- W2622017248 title "Effects of age, immune landscape, and response to trastuzumab (H) in HER-2 positive (HER2+) breast cancer in NCCTG (Alliance)-N9831." @default.
- W2622017248 doi "https://doi.org/10.1200/jco.2017.35.15_suppl.530" @default.
- W2622017248 hasPublicationYear "2017" @default.
- W2622017248 type Work @default.
- W2622017248 sameAs 2622017248 @default.
- W2622017248 citedByCount "0" @default.
- W2622017248 crossrefType "journal-article" @default.
- W2622017248 hasAuthorship W2622017248A5014209331 @default.
- W2622017248 hasAuthorship W2622017248A5026692399 @default.
- W2622017248 hasAuthorship W2622017248A5027821205 @default.
- W2622017248 hasAuthorship W2622017248A5031005364 @default.
- W2622017248 hasAuthorship W2622017248A5033771723 @default.
- W2622017248 hasAuthorship W2622017248A5034422841 @default.
- W2622017248 hasAuthorship W2622017248A5052187738 @default.
- W2622017248 hasAuthorship W2622017248A5057155689 @default.
- W2622017248 hasAuthorship W2622017248A5065306642 @default.
- W2622017248 hasAuthorship W2622017248A5082913203 @default.
- W2622017248 hasConcept C121608353 @default.
- W2622017248 hasConcept C126322002 @default.
- W2622017248 hasConcept C143998085 @default.
- W2622017248 hasConcept C203014093 @default.
- W2622017248 hasConcept C207103383 @default.
- W2622017248 hasConcept C2777226972 @default.
- W2622017248 hasConcept C2777575956 @default.
- W2622017248 hasConcept C2779056147 @default.
- W2622017248 hasConcept C2779786085 @default.
- W2622017248 hasConcept C44249647 @default.
- W2622017248 hasConcept C530470458 @default.
- W2622017248 hasConcept C71924100 @default.
- W2622017248 hasConcept C8891405 @default.
- W2622017248 hasConceptScore W2622017248C121608353 @default.
- W2622017248 hasConceptScore W2622017248C126322002 @default.
- W2622017248 hasConceptScore W2622017248C143998085 @default.
- W2622017248 hasConceptScore W2622017248C203014093 @default.
- W2622017248 hasConceptScore W2622017248C207103383 @default.
- W2622017248 hasConceptScore W2622017248C2777226972 @default.
- W2622017248 hasConceptScore W2622017248C2777575956 @default.
- W2622017248 hasConceptScore W2622017248C2779056147 @default.
- W2622017248 hasConceptScore W2622017248C2779786085 @default.
- W2622017248 hasConceptScore W2622017248C44249647 @default.
- W2622017248 hasConceptScore W2622017248C530470458 @default.
- W2622017248 hasConceptScore W2622017248C71924100 @default.
- W2622017248 hasConceptScore W2622017248C8891405 @default.
- W2622017248 hasLocation W26220172481 @default.
- W2622017248 hasOpenAccess W2622017248 @default.
- W2622017248 hasPrimaryLocation W26220172481 @default.
- W2622017248 hasRelatedWork W1860228378 @default.
- W2622017248 hasRelatedWork W2019967809 @default.
- W2622017248 hasRelatedWork W2078068853 @default.
- W2622017248 hasRelatedWork W2091805528 @default.
- W2622017248 hasRelatedWork W2152549152 @default.
- W2622017248 hasRelatedWork W2310231512 @default.
- W2622017248 hasRelatedWork W2407234744 @default.
- W2622017248 hasRelatedWork W2521578129 @default.
- W2622017248 hasRelatedWork W2740476111 @default.
- W2622017248 hasRelatedWork W2793907310 @default.
- W2622017248 hasRelatedWork W2884793177 @default.
- W2622017248 hasRelatedWork W2886718538 @default.
- W2622017248 hasRelatedWork W2911681680 @default.
- W2622017248 hasRelatedWork W2945440162 @default.
- W2622017248 hasRelatedWork W2980393696 @default.
- W2622017248 hasRelatedWork W2996721496 @default.
- W2622017248 hasRelatedWork W3013476923 @default.
- W2622017248 hasRelatedWork W3044945681 @default.
- W2622017248 hasRelatedWork W3142570532 @default.
- W2622017248 hasRelatedWork W3204042287 @default.
- W2622017248 isParatext "false" @default.
- W2622017248 isRetracted "false" @default.
- W2622017248 magId "2622017248" @default.
- W2622017248 workType "article" @default.